Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by knowsbeston Jan 05, 2021 1:09pm
179 Views
Post# 32224604

Seriously ask yourself.. ask anybody

Seriously ask yourself.. ask anybody
 
"These testing sites are performing 36x86=3096 testing per day, generating USD 294,120 and Canadian $373,532 per day, $11,205,972 per month and $134,471,664 per year. Medivolve projected EBTIDA is 55% and with that $73,959,415 EBTIDA profit per year. "

With this kinds of projections what kind of business will give a good part of the business for less than 1/2 of your monthly sales ???

That tells you everything you need to know .ITS ALL BS AND IS BAD FOR YOU

These testing sites are performing 36x86=3096 testing per day, generating USD 294,120 and Canadian $373,532 per day, $11,205,972 per month and $134,471,664 per year. Medivolve projected EBTIDA is 55% and with that $73,959,415 EBTIDA profit per year. 1. 1300 Folsom Blvd 95630 Folsom CA
<< Previous
Bullboard Posts
Next >>